SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-003933
Filing Date
2024-01-08
Accepted
2024-01-08 08:06:01
Documents
14
Period of Report
2024-01-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d45395d8k.htm   iXBRL 8-K 26653
2 EX-99.1 d45395dex991.htm EX-99.1 11346
6 GRAPHIC g45395g0106075508625.jpg GRAPHIC 4960
  Complete submission text file 0001193125-24-003933.txt   167654

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cort-20240108.xsd EX-101.SCH 2849
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cort-20240108_lab.xml EX-101.LAB 17234
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cort-20240108_pre.xml EX-101.PRE 10811
8 EXTRACTED XBRL INSTANCE DOCUMENT d45395d8k_htm.xml XML 3273
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50679 | Film No.: 24518430
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)